Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Fecal Microbiota Transplant National Registry
NCT03325855 · View on ClinicalTrials.gov ↗
Study Summary
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
Conditions Studied
Interventions
- OTHER None - Observational
Study Locations (20)
California
- Children's Hospital of Los Angeles — Los Angeles
- University of California — Los Angeles
- Stanford University — Redwood City
- Sutter Roseville Medical Center — Roseville
- University of California San Francisco — San Francisco
- Ventura Clinical Trials — Ventura
Illinois
- The University of Chicago — Chicago
- University of Chicago School of Medicine — Chicago
- NorthShore University Health System — Evanston
- Loyola University Medical Center — Maywood
- Loyola University of Chicago/ Loyola University Medical Center — Maywood
- Carle Foundation Hospital — Urbana
Florida
- Best Quality Research, Inc. — Hialeah
- University of Miami, Miller School of Medicine — Miami
- GI Pros — Naples
Arizona
- Phoenix Children's Hospital — Phoenix
Connecticut
- Yale New Haven Hospital — Hamden
District of Columbia
- MedStar Georgetown University Hospital — Georgetown
Georgia
- Emory University School of Medicine — Atlanta
Indiana
- Indiana University School of Medicine — Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,000 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2027-08 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03325855
The ClinicalTrials.gov registry entry for NCT03325855 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 4,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Gastroenterological Association, which has 1 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Gut Microbiome appearing as the primary indexed condition, and to 1 intervention — of which None - Observational is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03325855 reports 20 study locations spanning 8 distinct geographic areas — top geographies include California, Illinois, Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03325855 about?
NCT03325855 is a clinical study titled "Fecal Microbiota Transplant National Registry". A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
What is the current status of trial NCT03325855?
This trial is currently recruiting. The enrollment target is 4,000 participants. The study started on 2017-09-20. Estimated completion is 2027-08.
What conditions does trial NCT03325855 study?
This clinical trial studies the following conditions: Gut Microbiome, Clostridium Difficile Infection, Fecal Microbiota Transplantation. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT03325855?
The interventions under investigation include: None - Observational (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT03325855?
This trial is sponsored by American Gastroenterological Association, which has 1 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03325855 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.